Set Your Sights On Gossamer Bio Inc (NASDAQ: GOSS)’S Upside Potential
Gossamer Bio Inc (GOSS) concluded trading on Thursday at a closing price of $1.23, with 3.17 million shares of worth about $3.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.76% during that period and on July 11, 2024 the price saw a […]
Why Should You Put Gossamer Bio Inc (NASDAQ: GOSS) On Your Portfolio?
Currently, there are 225.41M common shares owned by the public and among those 189.51M shares have been available to trade. The company’s stock has a 5-day price change of 0.99% and -62.31% over the past three months. GOSS shares are trading -43.00% year to date (YTD), with the 12-month market performance down to -62.04% lower. […]
Gossamer Bio Inc (NASDAQ: GOSS): Stock That Needs Special Handling
The Vanguard Group, Inc. recently announced the acquisition of new stake in Gossamer Bio Inc (NASDAQ:GOSS). The institutional investor has increased its shareholding in the Healthcare company by 214.45% to 11.17 million shares with purchase of 7.62 million shares. This fresh investment now brings its stake to 4.96% valued currently at $5.58 million. In addition, […]
Gossamer Bio Inc (NASDAQ: GOSS): Analyst View Points To Future Growth
Gossamer Bio Inc (GOSS) concluded trading on 11/15/23 at a closing price of $0.81, with 4.96 million shares of worth about $4.02 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.58% during that period and on Wednesday the price saw a gain of […]
